Lichen sclerosus in a breast cancer survivor on an aromatase inhibitor: a case report.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 22956445.
- Also identified by DOI 10.1007/s11606-012-2209-z and PMC identifier 3599029.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Lichen sclerosus is a commonly misdiagnosed disease that is characterized by thinned, hypopigmented, crinkled skin that often forms a figure-eight shape around the vaginal and anal openings. We present a case of advanced lichen sclerosus in a 53-year-old female patient prescribed a nonsteroidal aromatase inhibitor after the excision of a breast cancer tumor. We present a diagnostic approach to lichen sclerosus by recognizing its common figure-eight pattern, and we review the known causes and treatment of lichen sclerosus. Research has shown that lichen sclerosus is more common in low estrogen states, and thus it is logical that aromatase inhibitors could increase a patient's risk for developing this disease. We therefore propose that all patients prescribed aromatase inhibitors undergo regular vulvo-vaginal exams to rule out lichen sclerosus and other hypoestrogen-related vulvo-vaginal problems.
Medical subject headings
- Antineoplastic Agents, Hormonal
- Aromatase Inhibitors
- Breast Neoplasms
- Nitriles
- Triazoles
- Vulvar Lichen Sclerosus